Published Paper Details:

BACKGROUND: Sarcopenia, a progressive loss of skeletal muscle mass, strength, and function, is associated with aging, disease, or inactivity and increases the risk of falls, fractures, disability, and mortality. A systematic review and meta-analysis by Fanny Petermann Rocha (2021) revealed that the prevalence of sarcopenia and severe sarcopenia varies significantly depending on diagnostic criteria, underscoring the need for standardized guidelines to ensure consistent comparisons across populations. AIM AND OBJECTIVE: The aim of the study is to analyse the prevalence of sarcopenia among the geriatric population using SCAR-F questionnaire and to determine prevalence of sarcopenia using bio impedance analysis. METHODOLOGY: The prevalence of sarcopenia was assessed in 200 older adults aged 50-80 years over a four-week period using a convenience sampling method. The study was conducted at selected clinics and participants' homes. Inclusion criteria comprised willing, lean older adults, while individuals with psychological disorders, recent surgeries, or traumatic injuries were excluded. Sarcopenia assessment was performed using the SARC-F questionnaire in combination with Bioelectrical Impedance Analysis (BIA). RESULT: Sarcopenia prevalence was highest (89%) among individuals aged 80-90 years. Age was significantly associated with sarcopenia, whereas gender showed no significant relationship. SARC-F scores demonstrated a strong correlation with age and muscle strength, with all predictors except gender reaching statistical significance. CONCLUSION: The findings of this study demonstrate a significant association between age and sarcopenia prevalence, underscoring the importance of early screening and intervention. Results support the use of the SARC-F questionnaire and Bioelectrical Impedance Analysis (BIA) as practical tools for preliminary assessment of sarcopenia.